Those were the conclusions of a new study by Henry Ford Hospital researchers who examined the medical records of epilepsy surgery patients and conducted a telephone survey to determine their satisfaction with the results of the procedure.
"Overall, the great majority of patients, 92 percent of them, expressed satisfaction with undergoing epilepsy surgery," says Vibhangini S. Wasade, M.D., a Henry Ford Hospital neurologist and lead author of the study.
"Following surgery, more patients were able to drive, and those with favorable seizure outcomes were more likely to be employed full-time and less likely to be taking antidepressant medication," Dr. Wasade adds.
The research will be presented at the American Epilepsy Society's 67th Annual Meeting in Washington, DC, by Marianna Spanaki-Varelas, M.D., the study's co-author and division head of the Henry Ford Comprehensive Epilepsy Program.
Each of the patients in the study group underwent resective surgery, in which the affected portion of their brain is removed, to treat refractory partial epilepsy. Refractory epilepsy, which affects about a third of those with the seizure disorder, is a form that resists treatment with medications.
The condition can severely damage patients' quality of life, leaving them wary of their next unpredictable seizure, limiting their ability to work full-time or successfully attend school and sometimes causing seizure-related injuries.
In such cases, resective surgery is considered an effective treatment. The most common procedure – temporal resection – involves removing the affected portion of the temporal lobe.
In other instances, seizure surgery is extra-temporal, in which a portion of the brain outside the temporal lobes – including the frontal, parietal or occipital lobes – is removed.
Henry Ford researchers used its databases to identify patients who had epilepsy surgery from 1993 to 2011. Of those 420 patients, 253 were surveyed by telephone to determine their current seizure frequency, driving status, employment status and use of antidepressants.
Of the 253 patients surveyed:
82 patients (32 percent) were seizure free, and 189 (75 percent) had a favorable outcome.
Temporal resection was performed on 215 patients (85 percent) of the study group, with significant favorable outcomes.
Patients were more likely to be driving compared to before their surgery (51 percent versus 35 percent).
The difference in current full-time employment status was significantly higher in temporal resections compared to extra-temporal – (45 percent versus 26 percent).
Patients with favorable surgical outcomes were more likely to be driving (65 percent versus 11 percent), employed – (28 percent versus 8 percent), and less likely to be taking anti-depressants – (24 percent versus 47 percent), compared to those without favorable outcomes.
The other co-investigators of this study are Jason Schwalb, M.D., Rizwan Tahir, M.D., and Lonni Schultz, Ph.D., from Henry Ford Hospital, and Kost Elisevich, M.D., and Brien Smith, M.D., from Spectrum Health System.
Editors Note: Authors of this study will be available at a press briefing at 9am (EDT), Dec. 8, in the onsite pressroom, Room 209-A, Level 2 of the Walter E. Washington Convention Center. The call-in number for off-site journalists is 1-605-475-4000, passcode 521653#.
Dwight Angell | EurekAlert!
Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center
Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy